Neurofibromatosis News and Research

RSS
Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.
Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

Genetic differences between brain cancer cells and normal tissues could offer clues to tumor behavior

TSRI scientists discover key molecular player in inherited disorder and morphine addiction

TSRI scientists discover key molecular player in inherited disorder and morphine addiction

Neurofibromatosis causes benign tumor formation in normal nervous tissue

Neurofibromatosis causes benign tumor formation in normal nervous tissue

Common pain and anti-inflammation drugs may slow cancer growth

Common pain and anti-inflammation drugs may slow cancer growth

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Cancer causing genetic condition risk in children lower than previously thought

Cancer causing genetic condition risk in children lower than previously thought

UAB lab to offer new tests for genetic diseases using next-generation sequencing

UAB lab to offer new tests for genetic diseases using next-generation sequencing

Anticancer drug restores hearing in neurofibromatosis patients

Anticancer drug restores hearing in neurofibromatosis patients

UAB research explores neurofibromatosis type 1

UAB research explores neurofibromatosis type 1

Neurocutaneous disorders affect skin, nervous system

Neurocutaneous disorders affect skin, nervous system

New study reveals why some vestibular schwannomas cause hearing loss

New study reveals why some vestibular schwannomas cause hearing loss

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

UT Southwestern surgeons help pioneer minimally invasive ear surgery

UT Southwestern surgeons help pioneer minimally invasive ear surgery

UCSF researchers lead $10 million research project on pediatric cancer

UCSF researchers lead $10 million research project on pediatric cancer

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Huntsman Cancer Institute receives NCI's Comprehensive Cancer Center designation

Huntsman Cancer Institute receives NCI's Comprehensive Cancer Center designation